CREX(CREX)
CREX
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
| Metric | FY2026E | FY2027E |
|---|---|---|
| Revenue Avg | $101M | $114M |
| Low | $99M | $110M |
| High | $102M | $116M |
| EBITDA Avg | $9M | $10M |
| Low | $9M | $9M |
| High | $9M | $10M |
| EBIT Avg | $509,167 | $576,737 |
| Low | $500,946 | $557,714 |
| High | $514,538 | $586,402 |
| Net Income Avg | $-11M | $912,534.5 |
| Low | $-12M | $896,643 |
| High | $-11M | $928,426 |
| EPS Avg | $-1.09 | $0.09 |
| Low | $-1.10 | $0.09 |
| High | $-1.07 | $0.09 |
| Analysts (Rev / EPS) | 2 / 2 | 3 / 2 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 |
|---|---|---|---|---|---|---|
| Revenue Avg | $26M | $37M | $20M | $24M | $29M | $40M |
| Low | $26M | $36M | $20M | $24M | $29M | $40M |
| High | $26M | $38M | $20M | $24M | $29M | $41M |
| EBITDA Avg | $2M | $3M | $2M | $2M | $2M | $3M |
| Low | $2M | $3M | $2M | $2M | $2M | $3M |
| High | $2M | $3M | $2M | $2M | $3M | $4M |
| EBIT Avg | $131,763 | $186,049 | $101,526 | $120,601 | $146,775 | $203,001 |
| Low | $130,029 | $181,987 | $100,189 | $119,014 | $144,843 | $200,329 |
| High | $133,804 | $190,833 | $103,098 | $122,470 | $149,048 | $206,146 |
| Net Income Avg | $-2M | $739,760 | $-3M | $-2M | $-898,280 | $2M |
| Low | $-3M | $727,102 | $-3M | $-2M | $-916,370 | $2M |
| High | $-2M | $754,657 | $-3M | $-2M | $-882,909 | $2M |
| EPS Avg | $-0.23 | $0.07 | $-0.29 | $-0.20 | $-0.09 | $0.21 |
| Low | $-0.28 | $0.07 | $-0.30 | $-0.20 | $-0.09 | $0.21 |
| High | $-0.17 | $0.07 | $-0.29 | $-0.19 | $-0.08 | $0.22 |
| Analysts (Rev / EPS) | 2 / 3 | 3 / 3 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 |